Evidence map›Paper›PMID 29628019›Full record

ArticleInfectious diseases of poverty2018

Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone.

Joseph B Koroma, Santigie Sesay, Abdul Conteh, Benjamin Koudou, Jusufu Paye, Mohamed Bah, Mustapha Sonnie, Mary H Hodges, Yaobi Zhang, Moses J Bockarie

Open access · goldAbstract read
In one paragraph

Article in Infectious diseases of poverty, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 4 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 4 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. The Threat of Vector-Borne Diseases in Sierra Leone.The American journal of tropical medicine and hygiene · 2023
    Review
  11. Mass drug administration targetingParasite epidemiology and control · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Joseph B KoromaFamily Health International (FHI) 360, Ghana Country Office, Accra, Ghana.
Santigie SesayNational Neglected Tropical Disease Control Programme, Ministry of Health and Sanitation, Freetown, Sierra Leone.
Abdul ContehNational Neglected Tropical Disease Control Programme, Ministry of Health and Sanitation, Freetown, Sierra Leone.
Benjamin KoudouCentre for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, Liverpool, UK.
Jusufu PayeHelen Keller International, Freetown, Sierra Leone.
Mohamed BahHelen Keller International, Freetown, Sierra Leone.
Mustapha SonnieHelen Keller International, Freetown, Sierra Leone.
Mary H HodgesHelen Keller International, Freetown, Sierra Leone.
Yaobi ZhangHelen Keller International, Regional Office for Africa, Dakar, Senegal. yzhang@hki.org.ORCID http://orcid.org/0000-0002-7370-9171
Moses J BockarieEuropean & Developing Countries Clinical Trials Partnership (EDCTP), Medical Research Council, Cape Town, South Africa.
Helen Keller International · USMinistry of Health and Sanitation · SLFamily Health International 360 · USLiverpool School of Tropical Medicine · GBSouth African Medical Research Council · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOnchocerciasis is endemic in 12 of the 14 health districts of Sierra Leone. Good treatment coverage of community-directed treatment with ivermectin was achieved between 2005 and 2009 after the 11-year civil conflict. Sentinel site surveys were conducted in 2010 to evaluate the impact of five annual rounds of ivermectin distribution.

methodsIn total, 39 sentinel villages from hyper- and meso-endemic areas across the 12 endemic districts were surveyed using skin snips in 2010. Results were analyzed and compared with the baseline data from the same 39 villages.

resultsThe average microfilaridermia (MF) prevalence across 39 sentinel villages was 53.10% at baseline. The MF prevalence was higher in older age groups, with the lowest in the age group of 1-9 years (11.00%) and the highest in the age group of 40-49 years (82.31%). Overall mean MF density among the positives was 28.87 microfilariae (mf)/snip, increasing with age with the lowest in the age group of 1-9 years and the highest in the age group of 40-49 years. Males had higher MF prevalence and density than females. In 2010 after five rounds of mass drug administration, the overall MF prevalence decreased by 60.26% from 53.10% to 21.10%; the overall mean MF density among the positives decreased by 71.29% from 28.87 mf/snip to 8.29 mf/snip; and the overall mean MF density among all persons examined decreased by 88.58% from 15.33 mf/snip to 1.75 mf/snip. Ten of 12 endemic districts had > 50% reduction in MF prevalence. Eleven of 12 districts had ≥50% reduction in mean MF density among the positives.

conclusionsA significant reduction of onchocerciasis MF prevalence and mean density was recorded in all 12 districts of Sierra Leone after five annual MDAs with effective treatment coverage. The results suggested that the onchocerciasis elimination programme in Sierra Leone was on course to reach the objective of eliminating onchocerciasis in the country by the year 2025. Annual MDA with ivermectin should continue in all 12 districts and further evaluations are needed across the country to assist the NTDP with programme decision making.

Indexed as

AdolescentAdultAgedAnimalsChildChild, PreschoolFemaleFilaricidesHumansInfantIvermectinMaleMass Drug AdministrationMicrofilariaeMiddle AgedOnchocerca volvulusFilaricidesIvermectinCommunity-directed drug distributorCommunity-directed treatment with ivermectinDisease eliminationMass drug administrationOnchocerca volvulusOnchocerciasisOnchocerciasis-endemicPost-conflictRapid diagnostic testSkin snip

Identifiers

PMID29628019
PMCPMC5890354
OpenAlexW2801570975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.